Procaps Group, S.A. Ordinary Shares
PROC
PROC: Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
moreShow PROC Financials
Recent trades of PROC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PROC's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Extracts of Apr. 06, 2021
-
Patent Title: Method and apparatus for printing on soft gelatin capsules during forming Jun. 03, 2014
Federal grants, loans, and purchases
Followers on PROC's company Twitter account
Number of mentions of PROC in WallStreetBets Daily Discussion
Recent insights relating to PROC
Recent picks made for PROC stock on CNBC
ETFs with the largest estimated holdings in PROC
Flights by private jets registered to PROC